Table 5.
Genes with significant expression in high responders* (n=10) vs. low responders** (n=9)
|
After marathon training - Decreased gene expression | ||
|---|---|---|
| Transcript id | Gene | Fold change (FC) |
| 7969794 |
LOC100132099 |
−1.58 |
| 8049530 |
LRRFIP1 |
−1.58 |
| 7919269 |
RNU1-1 |
−1.89 |
| 7919349 |
RNU1-1 |
−1.89 |
| 7898375 |
RNU1-1 |
−1.86 |
| 7898411 |
RNU1-1 |
−1.86 |
| 7912800 |
RNU1-1 |
−1.86 |
| 7912850 |
RNU1-1 |
−1.86 |
| 7919576 |
RNU1-1 |
−1.86 |
| 7973896 |
RNU1-1 |
−1.85 |
| 7978568 |
RNU1-1 |
−1.85 |
| 7897801 |
RNU5E |
−1.89 |
| 7920873 |
SNORA42 |
−3.49 |
| 8117018 |
--- |
−1.86 |
| 7932635 |
--- |
−1.63 |
| 7965150 |
--- |
−1.62 |
|
After marathon training - increased gene expression | ||
|
Transcript id |
Gene |
Fold change (FC) |
| 8005225 | LOC162632 | 2.35 |
No genes met FDR significance criteria for differential mRNA expression in blood collected at baseline.
*High Responders are defined as those individuals who fell in the upper quartile (upper 25%) of percent change in rVO2 max.
**Low Responders are defined as those individuals who fell below the upper quartile of percent change in rVO2 max.